Floatz logo

Tazarotene

Hand-Foot Skin Reaction (HFSR)

Dana-Farber Cancer InstituteSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Hand-Foot Skin Reaction (HFSR) cohort.

Asset / SponsorPhaseRating
Inno-206
Swiss Cancer Institute
Phase 3BB
Mecobalamin
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3B
Dfn-15
Affiliated Hospital of Qinghai University
Phase 3B
ADVICOR COMPONENT NIACIN
First People's Hospital of Hangzhou
Phase 2CCC
INDOMETACINUM
National Taiwan University Hospital
Phase 2CCC

View all 11 →

Same molecule, other indications

Tazarotene is also rated in:

IPFDormant
B
Indicative ·
57 / 100
View asset →
idiopathic pulmonary fibrosisDormant
CCC
Indicative ·
54 / 100
View asset →
primary cutaneous T-cell non-Hodgkin lymphomaDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →